{
    "organizations": [],
    "uuid": "91b960b82bf78c56d75ca96dd4dc0b369c533536",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-esperite-signs-strategic-agreement/brief-esperite-signs-strategic-agreement-with-bgi-genomics-for-whole-genome-sequencing-idUSFWN1PQ0YQ",
    "ord_in_thread": 0,
    "title": "BRIEF-Esperite ‍Signs Strategic Agreement With BGI Genomics For Whole Genome Sequencing",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 31 (Reuters) - ESPERITE NV:\n* ‍SIGNS STRATEGIC AGREEMENT WITH BGI GENOMICS TO OFFER WHOLE GENOME SEQUENCING ON A LARGE SCALE​\n* ‍ISSUED A CONVERTIBLE NOTED IN FAVOR OF BGI FOR AN AMOUNT OF 520,000 EUROS, MATURITY 12 MONTHS AND INTEREST RATE 1%​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-01-31T20:36:00.000+02:00",
    "crawled": "2018-02-01T14:57:26.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "esperite",
        "nv",
        "strategic",
        "agreement",
        "bgi",
        "genomics",
        "offer",
        "whole",
        "genome",
        "sequencing",
        "large",
        "convertible",
        "noted",
        "favor",
        "bgi",
        "amount",
        "euro",
        "maturity",
        "month",
        "interest",
        "rate",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}